XY
Therapeutic Areas
CanSino Biologics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Recombinant Zoster Vaccine (Adenovirus Vector) | Herpes Zoster Prevention | Phase 2 |
| Inhaled Tuberculosis Vaccine (Ad5 Vector) | TB Booster | Phase 2 |
| Recombinant Poliomyelitis vaccine (PBPV) | Poliomyelitis Prevention | Phase 1 |
| DTcP-Hib-MCV4 Combined Vaccine | Diphtheria, Tetanus, Pertussis, Hib, Meningococcal Prevention | Phase 1 |
| CS-2606 mRNA Multi-valent Influenza Vaccine | Influenza Prevention | Pre-clinical |
| 24-valent Pneumococcal Conjugate Vaccine | Pneumococcal Disease Prevention | Pre-clinical |
| Convidecia Air® (XBB.1.5 Variant) | COVID-19 Prevention | Approved |